Vincenza Spallone1. 1. Endocrinology, Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier, 1, 00133, Rome, Italy. vispa@mclink.it.
Abstract
PURPOSE OF REVIEW: This review considers the relationship between abnormal blood pressure (BP) variability and autonomic dysfunction through an attempt to answer questions about its clinical relevance and pertinence to diabetes and cardiovascular autonomic neuropathy (CAN) and which therapeutic measures can lessen its cardiovascular impact. RECENT FINDINGS: Office, ambulatory, and home BP monitoring identify posture-related, circadian, short-term, and long-term BP variabilities. Abnormal BP variability is a risk marker for organ damage, mortality, and cardiovascular events. Moreover, BP variability changes are common in diabetes and associated with CAN and possibly exacerbated by comorbidities like nephropathy, obstructive sleep apnoea syndrome, and chronic pain. The prognostic role of nondipping and reverse dipping is well documented in diabetes. Some findings suggest the possibility of restoring dipping with the dosage time of antihypertensive agents. Diabetes is a favorable scenario for altered BP variability, which might mediate the harmful effects of CAN. Preliminary data suggest the protective effect of targeting BP variability. However, further longitudinal outcome studies are needed. In the meantime, BP variability measures and practical expedients in antihypertensive treatment should be implemented in diabetes.
PURPOSE OF REVIEW: This review considers the relationship between abnormal blood pressure (BP) variability and autonomic dysfunction through an attempt to answer questions about its clinical relevance and pertinence to diabetes and cardiovascular autonomic neuropathy (CAN) and which therapeutic measures can lessen its cardiovascular impact. RECENT FINDINGS: Office, ambulatory, and home BP monitoring identify posture-related, circadian, short-term, and long-term BP variabilities. Abnormal BP variability is a risk marker for organ damage, mortality, and cardiovascular events. Moreover, BP variability changes are common in diabetes and associated with CAN and possibly exacerbated by comorbidities like nephropathy, obstructive sleep apnoea syndrome, and chronic pain. The prognostic role of nondipping and reverse dipping is well documented in diabetes. Some findings suggest the possibility of restoring dipping with the dosage time of antihypertensive agents. Diabetes is a favorable scenario for altered BP variability, which might mediate the harmful effects of CAN. Preliminary data suggest the protective effect of targeting BP variability. However, further longitudinal outcome studies are needed. In the meantime, BP variability measures and practical expedients in antihypertensive treatment should be implemented in diabetes.
Authors: Paolo Verdecchia; Fabio Angeli; Giovanni Mazzotta; Marta Garofoli; Elisa Ramundo; Giorgio Gentile; Giuseppe Ambrosio; Gianpaolo Reboldi Journal: Hypertension Date: 2012-05-14 Impact factor: 10.190
Authors: Elisabeth A Lambert; Kanella Chatzivlastou; Markus Schlaich; Gavin Lambert; Geoffrey A Head Journal: Am J Hypertens Date: 2014-01-16 Impact factor: 2.689
Authors: V Spallone; L Bernardi; L Ricordi; P Soldà; M R Maiello; A Calciati; S Gambardella; P Fratino; G Menzinger Journal: Diabetes Date: 1993-12 Impact factor: 9.461
Authors: Chike C Nwabuo; Yuichiro Yano; Henrique T Moreira; Duke Appiah; Henrique D Vasconcellos; Queen N Aghaji; Anthony Viera; Jamal S Rana; Ravi V Shah; Venkatesh L Murthy; Norrina B Allen; Pamela J Schreiner; Donald M Lloyd-Jones; João A C Lima Journal: JAMA Cardiol Date: 2020-07-01 Impact factor: 14.676
Authors: Arnaud D Kaze; Prasanna Santhanam; Sebhat Erqou; Matthew Yuyun; Alain G Bertoni; Rexford S Ahima; Justin B Echouffo-Tcheugui Journal: Am J Hypertens Date: 2021-08-09 Impact factor: 3.080
Authors: Lilian de Souza D'Albuquerque Silva; Natércia Neves Marques de Queiroz; Franciane Trindade Cunha de Melo; João Felício Abrahão Neto; Luísa Corrêa Janaú; Norberto Jorge Kzan de Souza Neto; Manuela Nascimento de Lemos; Maria Clara Neres Iunes de Oliveira; Angélica Leite de Alcântara; Lorena Vilhena de Moraes; Wanderson Maia da Silva; Ícaro José Araújo de Souza; Nivin Mazen Said; Gabriela Nascimento de Lemos; Karem Miléo Felício; Márcia Costa Dos Santos; Ana Regina Bastos Motta; Melissa de Sá Oliveira Dos Reis; Isabel Jane Campos Lobato; Priscila Boaventura Barbosa de Figueiredo; Ana Carolina Contente Braga de Souza; Pedro Paulo Freire Piani; João Soares Felício Journal: Front Endocrinol (Lausanne) Date: 2020-11-19 Impact factor: 5.555
Authors: Ditte S Kornum; Astrid J Terkelsen; Davide Bertoli; Mette W Klinge; Katrine L Høyer; Huda H A Kufaishi; Per Borghammer; Asbjørn M Drewes; Christina Brock; Klaus Krogh Journal: J Clin Med Date: 2021-03-31 Impact factor: 4.241